Akeso, Inc. (9926) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sino Biopharmaceutical Ltd.

WuXi AppTec Co., Ltd.

China Medical System Holdings Ltd.

Sinopharm Group Co., Ltd.

China Resources Pharmaceutical Group Ltd.

Hygeia Healthcare Holdings Co., Ltd.

Hansoh Pharmaceutical Group Co., Ltd.

Innovent Biologics, Inc.

HUTCHMED (China) Ltd.

Akeso, Inc.

BeiGene Ltd.

Why is Akeso, Inc. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 8.59%

Poor long term growth as Operating profit has grown by an annual rate -15.87% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -53.96

Negative results in Jun 25

OPERATING CASH FLOW(Y) Lowest at HKD -1,629.78 MM
ROCE(HY) Lowest at -14.4%
DEBTORS TURNOVER RATIO(HY) Lowest at 3.47 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 59.66%, its profits have fallen by -124.5%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Akeso, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Akeso, Inc.

59.66%

3.57

68.82%

Hang Seng Hong Kong

8.25%

0.41

19.93%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

102.83%

EBIT Growth (5y)

-15.87%

EBIT to Interest (avg)

-53.96

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.50

Sales to Capital Employed (avg)

0.24

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

15.27%

ROE (avg)

8.59%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

19.27

EV to EBIT

-219.14

EV to EBITDA

-331.30

EV to Capital Employed

37.39

EV to Sales

59.12

PEG Ratio

Dividend Yield

ROCE (Latest)

-17.06%

ROE (Latest)

-7.49%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

CASH AND EQV(HY)

Highest at HKD 7,820.28 MM

NET SALES(Q)

At HKD 1,516.21 MM has Grown at 36.54%

-18What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD -1,629.78 MM

ROCE(HY)

Lowest at -14.4%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.47 times

RAW MATERIAL COST(Y)

Grown by 17.63% (YoY

DEBT-EQUITY RATIO (HY)

Highest at -40.35 %

INTEREST(Q)

Highest at HKD 68.06 MM

PRE-TAX PROFIT(Q)

Fallen at -78.18%

NET PROFIT(Q)

Lowest at HKD -620.44 MM

EPS(Q)

Lowest at HKD -0.68

Here's what is working for Akeso, Inc.

Net Sales

At HKD 1,516.21 MM has Grown at 36.54%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Cash and Eqv

Highest at HKD 7,820.28 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Depreciation

Highest at HKD 132.18 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 132.18 MM has Grown at 15.89%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Akeso, Inc.

Net Profit

At HKD -620.44 MM has Fallen at -132.32%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (HKD MM)

Debtors Turnover Ratio

Lowest at 3.47 times and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Operating Cash Flow

Lowest at HKD -1,629.78 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Interest

Highest at HKD 68.06 MM

in the last five periods and Increased by 183.93% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Pre-Tax Profit

Fallen at -78.18%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit

Lowest at HKD -620.44 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS

Lowest at HKD -0.68

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Debt-Equity Ratio

Highest at -40.35 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost

Grown by 17.63% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales